Stellate Ganglion Block With Lidocaine for the Treatment of COVID-19-Induced Parosmia (Stella)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06055270 |
Recruitment Status :
Recruiting
First Posted : September 26, 2023
Last Update Posted : April 5, 2024
|
Sponsor:
Lawson Health Research Institute
Information provided by (Responsible Party):
Leigh Sowerby, Lawson Health Research Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | December 24, 2025 |
Estimated Study Completion Date : | May 15, 2026 |
Publications of Results: